Model the biological battle between Asian citrus psyllid vectors, Candidatus Liberibacter asiaticus (HLB / greening), and next-generation EPA-approved genetic disease resistance, targeted peptide scions, and trunk injection micro-therapies.
Huanglongbing (HLB or citrus greening) is caused by the phloem-restricted unculturable bacterium Candidatus Liberibacter asiaticus (CLas). Injected by the Asian citrus psyllid (Diaphorina citri) during sap feeding, CLas causes excessive callose deposition in phloem sieve plates, choking off sucrose transport from leaves to roots. Root mass dies back up to 50% before foliar symptoms even appear, resulting in small, bitter, lopsided fruit and tree collapse.
New regulatory pathways have opened approvals for targeted plant-incorporated protectants (PIPs), synthetic antimicrobial peptides (SAMPs derived from spinach defensin), and CRISPR-based gene editing of susceptibility genes (such as Citrus CsLOB1 or salicylic acid pathway boosters). These engineered trees prevent bacterial proliferation without disrupting beneficial soil biomes or leaving chemical residues in juice.
Florida orange production dropped from over 240 million boxes in the late 1990s to under 18 million boxes following statewide HLB dissemination. Growers face massive capital expenditures ($2,500–$4,500/acre replanting costs) with a 3–4 year non-bearing juvenile period. Without reliable biotech immunity or therapeutic micro-injections (OTC), newly planted conventional trees become 100% infected within 24 months.